USA – FDA rolls out dashboard to track COVID-19 drugs

The US Food and Drug Administration (FDA) has launched a new public dashboard to track adverse event reporting for drugs and therapeutic biological products that have received emergency use authorization (EUA) to treat COVID-19.
 
The FDA Adverse Event Reporting System (FAERS) public dashboard for COVID-19 EUA products will be updated weekly, according to FDA’s landing page for the new initiative.  
 
In its inaugural week, the dashboard indicates that a total of 8,627 FAERS reports have been made, with 5,000 judged to be serious and an additional 1,404 reporting a death. Just over 3,000 of the total reports have been made in 2021.
 
In all, 5,526 of the FAERS reports have been directly submitted to FDA through its MedWatch program, either by consumers or by health care professionals